These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 2582439)
1. Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma. Gomella LG; Sargent ER; Wade TP; Anglard P; Linehan WM; Kasid A Cancer Res; 1989 Dec; 49(24 Pt 1):6972-5. PubMed ID: 2582439 [TBL] [Abstract][Full Text] [Related]
2. Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas. Petrides PE; Bock S; Bovens J; Hofmann R; Jakse G Cancer Res; 1990 Jul; 50(13):3934-9. PubMed ID: 2354442 [TBL] [Abstract][Full Text] [Related]
3. Southern blot analysis of transformed growth factor alpha and beta DNA in normal kidney and in renal cell carcinoma. Wade TP; Comelia LG; Sargent ER; Anglard P; Kasid A; Linehan WM Curr Surg; 1989; 46(5):401-3. PubMed ID: 2805783 [No Abstract] [Full Text] [Related]
4. Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Mydlo JH; Michaeli J; Cordon-Cardo C; Goldenberg AS; Heston WD; Fair WR Cancer Res; 1989 Jun; 49(12):3407-11. PubMed ID: 2720695 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-alpha production and autoinduction in a colorectal carcinoma cell line (DiFi) with an amplified epidermal growth factor receptor gene. Untawale S; Zorbas MA; Hodgson CP; Coffey RJ; Gallick GE; North SM; Wildrick DM; Olive M; Blick M; Yeoman LC Cancer Res; 1993 Apr; 53(7):1630-6. PubMed ID: 8453634 [TBL] [Abstract][Full Text] [Related]
6. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Grandis JR; Tweardy DJ Cancer Res; 1993 Aug; 53(15):3579-84. PubMed ID: 8339264 [TBL] [Abstract][Full Text] [Related]
7. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type. Ramp U; Jaquet K; Reinecke P; Schardt C; Friebe U; Nitsch T; Marx N; Gabbert HE; Gerharz CD J Urol; 1997 Jun; 157(6):2345-50. PubMed ID: 9146668 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells. Zipfel PA; Ziober BL; Morris SL; Mulder KM Cell Growth Differ; 1993 Aug; 4(8):637-45. PubMed ID: 8398905 [TBL] [Abstract][Full Text] [Related]
9. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. Bodmer S; Strommer K; Frei K; Siepl C; de Tribolet N; Heid I; Fontana A J Immunol; 1989 Nov; 143(10):3222-9. PubMed ID: 2809198 [TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis. Taketazu F; Kato M; Gobl A; Ichijo H; ten Dijke P; Itoh J; Kyogoku M; Rönnelid J; Miyazono K; Heldin CH Lab Invest; 1994 May; 70(5):620-30. PubMed ID: 8196359 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas. Liu C; Tsao MS Am J Pathol; 1993 Apr; 142(4):1155-62. PubMed ID: 8097369 [TBL] [Abstract][Full Text] [Related]
12. Expression of transforming growth factor alpha mRNA in benign and malignant tissues derived from gynecologic patients with various proliferative conditions. Xynos FP; Klos DJ; Hamilton PD; Schuette V; Fernandez-Pol JA Anticancer Res; 1992; 12(4):1115-20. PubMed ID: 1323947 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma. Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Derynck R; Goeddel DV; Ullrich A; Gutterman JU; Williams RD; Bringman TS; Berger WH Cancer Res; 1987 Feb; 47(3):707-12. PubMed ID: 3467839 [TBL] [Abstract][Full Text] [Related]
15. The growth promoting effect of transforming growth factor-alpha in human breast cancer cell lines. Kuranami M; Yamaguchi K; Asanuma F; Suzuki M; Abe K Jpn J Clin Oncol; 1989 Dec; 19(4):360-6. PubMed ID: 2607638 [TBL] [Abstract][Full Text] [Related]
16. Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung. Kim WS; Park C; Jung YS; Kim HS; Han J; Park CH; Kim K; Kim J; Shim YM; Park K Anticancer Res; 1999; 19(1A):301-6. PubMed ID: 10226558 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of transforming growth factor-beta 1 gene in 3LL metastatic variants. Perrotti D; Cimino L; Ferrari S; Sacchi A Cancer Res; 1991 Oct; 51(20):5491-4. PubMed ID: 1913669 [TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of mRNA for transforming growth factor-beta, type I and type III procollagen in human post-burn hypertrophic scar tissues. Ghahary A; Shen YJ; Scott PG; Gong Y; Tredget EE J Lab Clin Med; 1993 Oct; 122(4):465-73. PubMed ID: 8228562 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281 [TBL] [Abstract][Full Text] [Related]
20. In situ analysis of transforming growth factors-beta (TGF-beta 1, TGF-beta 2, TGF-beta 3) and TGF-beta type II receptor expression in basal cell carcinomas. Schmid P; Itin P; Rufli T Br J Dermatol; 1996 Jun; 134(6):1044-51. PubMed ID: 8763422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]